Funder
Funding for this study was provided by MSD, Novartis, Pfizer, Sanofi and the Bill and Melinda Gates Foundation (the Funders) through the New Venture Fund (NVF).
Publisher
Public Library of Science (PLoS)
Reference74 articles.
1. Global burden of hypertension: analysis of worldwide data;PM Kearney;Lancet,2005
2. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment;Lancet Diabetes Endocrinol,2014
3. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies;S Lewington;Lancet,2002
4. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants;Lancet,2017
5. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context;R Collins;Lancet,1990
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献